Campath-1h, a humanized monoclonal antibody, in refractory rheumatoid arthritis-Reference-Cited by-同舟云学术

Campath-1h, a humanized monoclonal antibody, in refractory rheumatoid arthritis

Published:1995-11 Issue:11 Volume:38 Page:1589-1594
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Weinblatt Michael E.,Maddison Peter J.,Bulpitt Ken J.,Hazleman Brian L.,Urowitz Murray B.,Sturrock Roger D.,Coblyn Jonathan S.,Maier Agnes L.,Spreen William R.,Manna Vasant K.,Johnston Jeffrey M.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference13 articles.

1. Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis

2. Treatment of refractory rheumatoid arthritis with a chimeric ANTI-CD4 monoclonal antibody

3. Effects of administration of an anti-cd5 plus immunoconjugate in rheumatoid arthritis. results of two phase ii studies

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders;Autoimmunity Reviews;2023-05

2. Alemtuzumab‐induced autoimmune thyroid events in patients with relapsing‐remitting multiple sclerosis: A real‐life and monocentric experience at a tertiary‐level centre;Clinical Endocrinology;2021-11

3. Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders;Therapeutic Advances in Neurological Disorders;2021-01

4. Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies;Chemical Science;2021

5. The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies;Frontiers in Immunology;2020-02-14